Tiffany, Kors to Re...
Health Care: Drugs
Meridian Bioscience Inc. (VIVO: NASDAQ)
$21.89 0.23 | 1.06%
05/24/13 - 04:00 PM ET
Company Balance Sheet
| Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 31.59M | 23.63M | 37.88M | 54.03M |
| Receivables | 24.18M | 24.84M | 22.06M | 26.98M |
| Inventories | 31.68M | 32.69M | 27.96M | 23.28M |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 96.59M | 90.35M | 94.02M | 117.15M |
| Property, Plant & Equipment, Gross | 63.22M | 60.51M | 56.41M | 53.20M |
| Accumulated Depreciation & Depletion | 37.07M | 33.97M | 33.69M | 32.72M |
| Property, Plant & Equipment, Net | 26.16M | 26.54M | 22.72M | 20.47M |
| Intangibles | 10.26M | 10.95M | 13.33M | 7.32M |
| Other Non-Current Assets | 1.27M | 4.53M | 1.24M | 1.19M |
| Total Non-Current Assets | 64.79M | 65.14M | 60.76M | 38.85M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 161.38M | 155.49M | 154.78M | 156.00M |
| Accounts Payable | 5.79M | 5.55M | 4.47M | 6.90M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 1.59M | 789.00K | 809.00K | 710.00K |
| Total Current Liabilities | 18.46M | 15.26M | 14.15M | 16.75M |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Income Taxes | 171.00K | 1.70M | 3.28M | 1.34M |
| Other Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 171.00K | 1.70M | 3.28M | 1.34M |
| Total Liabilities | 18.63M | 16.97M | 17.42M | 18.09M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 142.75M | 138.52M | 137.36M | 137.90M |
| Common Par | 0.00 | 0.00 | 0.00 | 0.00 |
| Additional Paid In Capital | 102.44M | 100.01M | 94.53M | 91.67M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | 40.21M | 38.06M | 42.18M | 45.52M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 95.00K | 449.00K | 655.00K | 722.00K |
| Total Capitalization | 142.75M | 138.52M | 137.36M | 137.90M |
| Total Equity | 142.75M | 138.52M | 137.36M | 137.90M |
| Total Liabilities & Stock Equity | 161.38M | 155.49M | 154.78M | 156.00M |
| Total Common Shares Outstanding | 41.28M | 41.24M | 40.65M | 40.49M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 41.08M | 40.72M | 40.52M | 40.39M |
| Diluted Weighted Shares Outstanding | 41.61M | 41.36M | 41.15M | 41.11M |
| Number of Employees | 510 | 525 | 498 | 422 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with VIVO
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorHighest-Yielding Drug Stocks
- Userhulkkims Portfolio 1
- ContributorBarron's Insider Purchases ...
- UserSUPRATRADE 20 Dividend Stoc...
- UserSUPRATRADE HOT STOCKS (BUY ...
- ContributorDividend Stocks for the Wee...
- Userrussbow98 Portfolio 1
- ContributorBarron's Insider Purchases ...
- ContributorBarron's Insider Purchases ...
Latest VIVO Headlines from TheStreet
- Meridian Bioscience Inc. Stock Upgraded (VIVO) 10.15.12 | 05:10 am
- Meridian Bioscience Inc. Stock Downgraded (VIVO) 08.22.12 | 05:08 am
- Meridian Bioscience Stock To Go Ex-dividend Tomorrow (VIVO) 05.01.12 | 09:05 am
- 8 Stocks Rising on Huge Volume 04.20.12 | 01:04 pm
- Meridian Bioscience Inc. Stock Upgraded (VIVO) 03.29.12 | 05:03 am
- Meridian Bioscience Rises On Unusually High Volume (VIVO) 02.01.12 | 03:02 pm
- Meridian Bioscience Stock To Go Ex-dividend Tomorrow (VIVO) 01.31.12 | 09:01 am
- Meridian Bioscience Stock To Go Ex-dividend Tomorrow (VIVO) 11.16.11 | 10:11 am
- Meridian Bioscience Stock Hits New 52-Week Low (VIVO) 10.03.11 | 09:10 am
- Meridian Bioscience Stock Hits New 52-Week Low (VIVO) 09.21.11 | 02:09 pm
Press Releases for VIVO
- Meridian Bioscience Recognized By Forbes As One Of America’s 100 Most Trustworthy Companies - Business Wire 03.28.13 | 11:03 am
- Meridian Bioscience Announces Illumigene® Group A Streptococcus And Illumigene® Group B Streptococcus Tests Categorized “Moderate Complexity” By FDA - Business Wire 03.18.13 | 11:03 am
- Bioline Launches ISOLATE II, A Precious Find For DNA And RNA Isolation - Business Wire 02.06.13 | 07:02 am
- Meridian Bioscience Reports First Quarter 2013 Operating Results And Reaffirms Fiscal 2013 Guidance - Business Wire 01.23.13 | 07:01 am
- Meridian Bioscience Successfully Completes Beta Trials For Two New Illumigene® Tests - Business Wire 12.13.12 | 02:12 pm
- Meridian Bioscience, Inc. Declares Regular Quarterly Dividend And Accelerates Payment Date To December 24, 2012 - Business Wire 12.04.12 | 10:12 am
- SensiFAST™ Genotyping Kit Exceed The Limit - Business Wire 11.28.12 | 07:11 am
- Meridian Bioscience Reports Fourth Quarter And Full-Year 2012 Operating Results, Declares Regular Cash Dividend, And Reaffirms Fiscal 2013 Guidance - Business Wire 11.08.12 | 07:11 am
- Meridian Bioscience Receives FDA Clearance For New Molecular Test: Illumigene® Group A Strep - Business Wire 09.17.12 | 03:09 pm
- Meridian Bioscience Provides Sales And Earnings Guidance For Fiscal 2013 And Reaffirms Fiscal 2012 Guidance - Business Wire 08.28.12 | 07:08 am
Partner Headlines for VIVO
- FDA Clears Meridian Ilumigene GAS - Analyst Blog - NASDAQ 09.20.12 | 04:09 pm
- Gilead REITERATED a Top Pick and 4 Stock Analyses Trending Now - Wall St. Cheat Sheet 07.27.12 | 12:07 pm
- Starbucks DOWNGRADED to Neutral and 4 Downgraded Shares Attracting Attention - Wall St. Cheat Sheet 07.27.12 | 03:07 am
- Meridian Bioscience Receives FDA Clearance for New Legionella Test - Benzinga 02.27.12 | 01:02 pm
- UPDATE: Wedbush Downgrades Meridian Bioscience to Underperform - Benzinga 01.31.12 | 09:01 am
- Dividend Stocks That Combine Growth And Income - Seeking Alpha 01.20.12 | 08:01 am
- FDA OKs Meridian's GDH Test - Analyst Blog - Zacks 01.05.12 | 10:01 am
- 30 'Overdue' Dividend Increases -- Will History Repeat Itself? - Seeking Alpha 08.19.11 | 06:08 pm
- FDA OKs Meridian C. difficile Test - Analyst Blog - Zacks 05.13.11 | 09:05 am
- Meridian Bioscience: An Overvalued Dividend Contender - Seeking Alpha 04.12.11 | 06:04 am
